Annual report pursuant to Section 13 and 15(d)

Note 3 - Summary of Significant Accounting Policies: Principles of Consolidation (Policies)

v3.8.0.1
Note 3 - Summary of Significant Accounting Policies: Principles of Consolidation (Policies)
12 Months Ended
Dec. 31, 2017
Policies  
Principles of Consolidation

Principles of Consolidation

 

The consolidated financial statements include the accounts of Zivo Bioscience, Inc. and its wholly-owned Subsidiaries, Health Enhancement Corporation, HEPI Pharmaceuticals, Inc., WellMetris, LLC, and Zivo Biologic, Inc. All significant intercompany transactions and accounts have been eliminated in consolidation.